Resolution Bioscience

Medtech · Acquired

Liquid biopsy platform for comprehensive genomic profiling of circulating tumor DNA to guide cancer treatment selection and monitor disease

Updated · resolutionbio.com

Sector
Medtech
Grants
—
No SBIR or STTR on record
Sector median 1 award
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
28
6 granted · 22 pending
14× sector median 2 patents

Capital Timeline

No federal awards or Form D filings are on record for this company.

Many early companies raise without filing a Form D, or have not yet won a federal award. New records appear here as the sources below update.

Checked: SEC EDGAR Form D through ; SBIR and STTR awards through ; USAspending contract awards

Peer position

Medtech · 4531 companies · ranked on federal contract value
Medtech companies ranked by federal contract value
#CompanyContractsDisclosed equity
2283Articulate Biosciences, LLC——
2284CAMERAD TECHNOLOGIES, LLC——
2285Retinal Registry——
2286Resolution Bioscience——
2287iAssay, Inc.——
2288CRYOSCOPE MEDICAL——
2289ETECTRX, INC.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Founders & Team

No people are linked to this company yet.

People appear here when they are named as related persons in the company's own Form D filings. We don't infer people from social profiles.

Checked: SEC EDGAR Form D related persons through

Patents

USPTO · 6 granted of 28

Regulatory activity · Medtech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.